ME/CFS Science @mecfsscience.org · 25/09/20251) There's a new review on the impact of ME/CFS. It concludes that "ME/CFS imposes a substantial health, social and economic burden of disease" but argues that its true burden may be even higher because many patients likely remain undiagnosed. 13210
ME/CFS Science @mecfsscience.org · 25/09/20252) The review included 20 studies. Unfortunately, the estimates of prevalence and costs vary widely based on the methodology used. Reported costs per patient, for example, ranged from USD 2,916 to USD 119,611. Prevalence estimates go from 0.02% to 2.5%. 140
